High Tower Advisors, LLC Abb Vie Inc. Call Options Transaction History

High Tower Advisors, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 06, 2024	BUY	$159.82 - $182.1 $5.51 Million - $6.28 Million	34,500 New	34,500 $6.28 Million
Q1 2022 May 12, 2022	SELL	$131.98 - $163.75 $37,482 - $46,505	-284 Reduced 94.67%	16 $21,000
Q2 2021 Aug 06, 2021	BUY	$105.21 - $117.21 $10,521 - $11,721	100 Added 50.0%	300 $0
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $13,140 - $16,796	200 New	200 $2,000

3,785

1.28B

13M

9.82M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $355B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.